Shared Resource Management

共享资源管理

• 批准号: 10627512
• 负责人: Gregory B. Lesinski
• 金额: $ 84.72万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-07 至 2028-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10627512
• 关键词: Applications Grants; Awareness; Cancer Center Support Grant; Capital; Cell Therapy; Data; Decision Making; Education; Equipment; Event; Extramural Activities; Fostering; Future; Goals; Grant; Growth; Human Resources; Immune; Infrastructure; Institution; Investments; Journals; Malignant Neoplasms; Modeling; Monitor; Needs Assessment; Peer Review; Peer Review Grants; Publications; Reporting; Research; Research Personnel; Research Priority; Resource Sharing; Science; Services; Strategic Planning; Strategic vision; Structure; Technology; Time; Universities; cost effective; data sharing networks; improved; member; operation; prevent; programs; square foot; stem; therapy development

PROJECT SUMMARY/ABSTRACT SHARED RESOURCE MANAGEMENT The overarching goal of the Winship shared resources (SRs) is to provide comprehensive research services and expertise to meet the present and future needs of Winship members across all four scientific research programs. Winship SRs have grown to nine `full' (six in the previous submission) and two `developing' SRs (dSR) that are aligned with the research programs through effective shared resource management (SRM). Two SRs (Data SR and Dissemination SR) transitioned from `developing' to `full' SRs and Flow SR launched during the reporting period to meet program member needs. These nine SRs highlight the growth in the SR service portfolio which stems from increased SR usage, needs-assessment of Winship researchers, and opportunistic partnerships across the university to expand services and align with the Winship strategic plan. SRM has three overarching aims that seek to provide cutting-edge and cost-effective SRs, deploy effective infrastructure and governance, and monitor the future scientific needs to guide the launch of new services and technologies. Winship SRs are integral to multiple team science grants, publications, major strategic research initiatives and educational events. Annual Winship SR usage by members increased 25% from 85 members in CY2016 to 106 members in CY2021 with a total SR usage of 149 unique Winship members from all programs during this time period. SR services have supported 539 peer-reviewed cancer-related publications (22% in journals with impact factor >10) from Winship members and 225 peer-reviewed grants from CY2016 to CY2021. Winship increased the space allocated to shared resources by >60%, with a total of 28,607 gross square feet (gsf) (up from 17,562 gsf in 2016), including a $5 million investment in the renovation of a newly renovated 8,800 gsf SR Hub. In total, Winship has invested $20.9 million in shared resources since 2017 resulting in the purchase of new equipment, newly renovated space, and hiring additional personnel. The future plans for SRM align with the Winship strategic plan and include capital and personnel investments in the developing Immune dSR and Cell Therapy dSR, growth of services/technologies in existing SRs, expanded Winship support for extramural SR grant applications, and expanded educational and diversity enhancement initiatives.

项目总结/摘要 共享资源管理 Winship共享资源（SR）的总体目标是提供全面的研究服务， 专业知识，以满足Winship成员在所有四个科学研究计划的当前和未来的需求。 Winship的工作人员代表已增加到9个“完整”工作人员代表（上次提交的是6个）和2个“发展中”工作人员代表， 通过有效的共享资源管理（SRM）与研究计划保持一致。两个SR（数据SR 从“发展中”过渡到“全面”的工作人员报告和在报告期间启动的流程工作人员报告 以满足会员的需求。这九个SR凸显了SR服务组合的增长， 源于SR使用的增加、Winship研究人员的需求评估以及机会主义伙伴关系 在整个大学，以扩大服务，并与Winship战略计划保持一致。SRM有三个主要的 旨在提供尖端且具有成本效益的员工代表，部署有效的基础设施和治理， 并监测未来的科学需求，以指导新服务和技术的推出。Winship SR是 不可或缺的多个团队科学赠款，出版物，重大战略研究计划和教育活动。 会员的年度Winship SR使用量从2016年的85名增加到2017年的106名，增长了25%。 CY 2021，在此期间，所有程序中共有149个唯一Winship成员使用SR。Sr 服务支持了539篇同行评审的癌症相关出版物（22%的期刊影响因子>10） 从2016年到2021年，Winship成员和225个同行评审赠款。Winship增加了空间 分配给共享资源的面积超过60%，共计28 607毛平方英尺（比2006年的17 562毛平方英尺有所增加）。 2016年），包括投资500万美元翻新新装修的8，800 gsf SR Hub。总的来说， 自2017年以来，Winship已投资2090万美元用于共享资源， 设备，新装修的空间和雇用额外的人员。SRM的未来计划与 Winship战略计划，包括在开发免疫dSR和细胞方面的资本和人员投资 治疗dSR，现有SR中服务/技术的增长，Winship对院外SR的支持扩展 赠款申请，扩大教育和多样性增强举措。